A novel, soluble homologue of the human IL-10 receptor with preferential expression in placenta

被引:57
作者
Gruenberg, BH
Schoenemeyer, A
Weiss, B
Toschi, L
Kunz, S
Wolk, K
Asadullah, K
Sabat, R
机构
[1] Schering AG, Dept Expt Dermatol, D-13342 Berlin, Germany
[2] Schering AG, Enabeling Technol Genom & Bioinformat, D-13342 Berlin, Germany
[3] Humboldt Univ, Med Sch Charite, Inst Med Immunol, D-10098 Berlin, Germany
关键词
CRF2; IL-10; family; IL-22; soluble receptor; bioinformatic search; pregnancy;
D O I
10.1038/sj.gene.6363786
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The cytokine receptor family type 2 (CRF2) comprises receptors for important immunomediators like interferons and interleukin-10 (IL-10). We identified a novel member of this family which represents the first exclusively soluble receptor in this group and was therefore designated as CRF2-soluble 1 (CRF2-s1). The CRF2-s1 gene covers about 28 kb and is located on chromosome 6 in close proximity to the CRF2 members interferon (IFN)-gamma receptor 1 and IL-20 receptor 1. It comprises seven exons and generates two different mRNA splice variants, CRF2-s1-long and CRF2-s1-short. CRF2-s1-long and CRF2-s1-short encode proteins of 263 and 231 amino acids, respectively. A comparison of predicted protein structures led to the postulation that each receptor variants binds a different ligand. Quantitative analysis of human mRNA expression revealed a very restricted pattern for both splice forms. CRF2-s1 turned out to be the first member of this receptor family which was expressed neither in resting nor in stimulated leucocyte populations. CRF2-s1-long was only expressed in placenta, whereas CRF2-s1-short was additionally expressed in human mammary gland and, at a lower level, in skin, spleen, thymus and stomach. The preferential expression of CRF2-s1 in placenta suggests a role for this receptor in establishing and maintaining successful pregnancy.
引用
收藏
页码:329 / 334
页数:6
相关论文
共 34 条
[1]   Effects of systemic interleukin-10 therapy on psoriatic skin lesions:: Histologic, immunohistologic, and molecular biology findings [J].
Asadullah, K ;
Friedrich, M ;
Hanneken, S ;
Rohrbach, C ;
Audring, H ;
Vergopoulos, A ;
Ebeling, M ;
Döcke, WD ;
Volk, HD ;
Sterry, W .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 116 (05) :721-727
[3]   Interleukin 20: Discovery, receptor identification, and role in epidermal function [J].
Blumberg, H ;
Conklin, D ;
Xu, WF ;
Grossmann, A ;
Brender, T ;
Carollo, S ;
Eagan, M ;
Foster, D ;
Haldeman, BA ;
Hammond, A ;
Haugen, H ;
Jelinek, L ;
Kelly, JD ;
Madden, K ;
Maurer, MF ;
Parrish-Novak, J ;
Prunkard, D ;
Sexson, S ;
Sprecher, C ;
Waggie, K ;
West, J ;
Whitmore, TE ;
Yao, L ;
Kuechle, MK ;
Dale, BA ;
Chandrasekher, YA .
CELL, 2001, 104 (01) :9-19
[4]   Cytokines as endogenous pyrogens [J].
Dinarello, CA .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 :S294-S304
[5]   Biologic basis for interleukin-1 in disease [J].
Dinarello, CA .
BLOOD, 1996, 87 (06) :2095-2147
[6]   Human interleukin-10-related T cell-derived inducible factor: Molecular cloning and functional characterization as an hepatocyte-stimulating factor [J].
Dumoutier, L ;
Van Roost, E ;
Colau, D ;
Renauld, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (18) :10144-10149
[7]   Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9 [J].
Dumoutier, L ;
Louahed, J ;
Renauld, JC .
JOURNAL OF IMMUNOLOGY, 2000, 164 (04) :1814-1819
[8]   IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes [J].
Dumoutier, L ;
Van Roost, E ;
Ameye, G ;
Michaux, L ;
Renauld, JC .
GENES AND IMMUNITY, 2000, 1 (08) :488-494
[9]   Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22 [J].
Dumoutier, L ;
Lejeune, D ;
Colau, D ;
Renauld, JC .
JOURNAL OF IMMUNOLOGY, 2001, 166 (12) :7090-7095
[10]   Soluble cytokine receptors: Their roles in immunoregulation, disease, and therapy [J].
FernandezBotran, R ;
Chilton, PM ;
Ma, YH .
ADVANCES IN IMMUNOLOGY, VOL 63, 1996, 63 :269-336